PPAR-gamma-independent inhibitory effect of rosiglitazone on glucose synthesis in primary cultured rabbit kidney-cortex tubules. (Q46314621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

PPAR-gamma-independent inhibitory effect of rosiglitazone on glucose synthesis in primary cultured rabbit kidney-cortex tubules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert Jarzyna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Rafal A Derlacz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Karol Hyc

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Michal Usarek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Adam K Jagielski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

Biochemistry and Cell Biology

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

396-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms

24 December 2019

cites work

1 reference

Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.

21 January 2018

1 reference

Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes.

21 January 2018

1 reference

Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans.

21 January 2018

1 reference

PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma

21 January 2018

1 reference

Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism

21 January 2018

1 reference

Amino-acid-dependent, differential effects of ethanol on glucose production in rabbit kidney-cortex tubules.

21 January 2018

1 reference

Glitazones and the cardiovascular system

21 January 2018

1 reference

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling

21 January 2018

1 reference

The effect of pioglitazone on the liver: role of adiponectin.

21 January 2018

1 reference

The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes

21 January 2018

1 reference

Renal gluconeogenesis: its importance in human glucose homeostasis

21 January 2018

1 reference

Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase

21 January 2018

1 reference

PPARgamma in human and mouse physiology

21 January 2018

1 reference

Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth

21 January 2018

1 reference

The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.

21 January 2018

1 reference

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

21 January 2018

1 reference

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

21 January 2018

1 reference

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus

21 January 2018

1 reference

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

21 January 2018

1 reference

Acute effects of pioglitazone on glucose metabolism in perfused rat liver.

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).

21 January 2018

1 reference

PPAR(gamma) and glucose homeostasis

21 January 2018

1 reference

Acute troglitazone action in isolated perfused rat liver

21 January 2018

1 reference

Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis

21 January 2018

1 reference

Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.

21 January 2018

1 reference

Important role of the kidney in human carbohydrate metabolism.

21 January 2018

1 reference

Hormonal regulation of phosphoenolpyruvate carboxykinase activity in liver and kidney of adult animals and formation of this enzyme in developing rabbit liver

21 January 2018

1 reference

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

21 January 2018

1 reference

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/O08-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923541%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference